The average total compensation package for a Director-level position at CRISPR Therapeutics in the United States ranges significantly based on specialized department, prior industry experience, and equity allocations, typically spanning between $210,000 and $265,000 in annual base salary. When incorporating additional compensation components—such as annual performance bonuses, cash incentives, and substantial stock option grants or restricted stock units inherent to leadership roles within top-tier biotechnology firms—total annual earnings frequently exceed $320,000 to $380,000, aligning with competitive compensation benchmarks across the Boston and San Francisco biotech hubs.